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Objectives: this study featured patients with affective bipolar disorder who were making use 
of lithium and received care at an outpatient care center located in a country town in the state 
of Sao Paulo in 2009; it assessed the adherence and knowledge of these patients in relation to 
the medication prescribed to them and verified the proportion of blood tests performed per year 
in the service, for each individual, to measure lithium levels in the blood. Method: descriptive 
study with quantitative approach, involving 36 participants. Structured interviews and review of 
medical records were used for data collection and descriptive statistics for data analysis. Results: 
difficulties in reporting the dosage of the medication prescribed and a high rate of non-adherence 
were identified among the participants. None of the participants in the study was submitted to 
two tests a year to measure lithium levels in the blood, which is the minimum proportion of tests 
recommended by the literature for maintenance treatment using lithium carbonate. Conclusion: 
this study highlights the critical factors for the promotion of patients’ safety in monitoring lithium 
drug therapy.
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Introduction
Bipolar disorder (BD) is serious, chronic and 
recurrent and it is present in about 1% to 2% of the 
population. For the bipolar spectrum, the estimative is 
higher, at about 5%, as the criteria adopted are less 
strict and conservative(1). BD has a serious impact on 
patients’ lives and it can cause functional damage, self-
care difficulties, socially unacceptable behavior and 
interpersonal relationship issues(2).
A continuous pharmacological treatment is needed 
to control this disorder. Thus, adherence to medication is 
essential for people with BD to respond satisfactorily to 
the treatment(3-4). Several factors, however, contribute 
to the poor adherence to medication, being the lack 
of knowledge about the medications an important 
factor(5-6). Therefore, the level of patients’ knowledge 
should be identified in planning nursing actions aimed at 
optimizing the treatment(7). 
Adherence to drug therapy is a subject of interest for 
the literature, since it is a factor that can be potentially 
modified in order to improve patients’ prognosis(3,8).
It can be highlighted that the BD treatment has 
a broad range of therapeutic resources but the “gold 
standard” medication for the treatment of this disorder 
is lithium carbonate(3,5,9-10). Although effective, this 
substance requires specific care as it has a narrow 
therapeutic range, high risk of intoxication(9-12) and slow 
onset of action, is subject to serum variation levels 
due to pharmacological interactions, and presents 
elimination and dosage-plasma level variations among 
people(7). The serum monitoring of lithium carbonate 
levels is important for treatment effectiveness and 
patients’ safety(9-12). Therefore, it is necessary to 
investigate whether this is being regularly carried out at 
psychological healthcare services.
The whole context shows that adherence to 
treatment(3-4,8), knowledge about the drug therapy(6-8) 
and serum monitoring of lithium carbonate levels(9,10-12) 
are essential for the safety of patients who make use of 
this medication. These aspects are strictly related to the 
nursing practice, which plays a unique role in patients’ 
education with the purpose of promoting adherence to 
medications and reducing the harm that may be caused 
by their inadequate use. Based on this, this study brings 
relevant contributions to nursing care in relation to 
people with affective bipolar disorder, in particular to 
those people undergoing lithium therapy.
Objective
This study is aimed at: identifying and characterizing 
patients with affective bipolar disorder using lithium 
carbonate and who were assisted at an outpatient care 
center located in a country town in the state of Sao Paulo, 
Brazil, in 2009; assessing the adherence and knowledge 
(name, dosage and frequency of use) of these patients in 
relation to the prescribed medications and verifying the 
proportion of blood tests performed in the service per year 
for each individual to measure lithium levels in the blood.
Method
This is a retrospective, cross sectional and descriptive 
study with a quantitative approach. It was carried out 
at a public health outpatient care center located in a 
country town in the state of Sao Paulo, Brazil. The project 
was undertaken upon approval by the Research Ethics 
Committee (Registration number 0206/CEP-CSE-FMRP-
USP) and all participants signed Informed Consent Forms.
All the eligible patients were those who had had 
medical appointment scheduled at the place of study 
during the period between 1 January and 31 December 
2009 and who fulfilled the following inclusion criteria: 
to have been diagnosed with affective bipolar disorder 
(established by the doctor responsible for outpatient 
care diagnosis); to have been prescribed the continuous 
use of lithium carbonate; to be 18 years old or over and 
to be able to verbally communicate in Portuguese. Only 
36 people assisted in this period fulfilled the inclusion 
criteria of this study.
For the collection of data, a review of medical 
records and structured interviews were performed, 
using a guide developed by the authors of the study 
with questions about socio-demographic information 
and patients’ treatment, as well as a test evaluating 
patients’ adherence to drug therapy(13) including lithium 
carbonate, and a scale to evaluate the interviewees’ 
knowledge concerning the prescribed drug therapy(14). 
The participants were interviewed in a private room at 
the healthcare center subject of this study.
The level of adherence was defined by Morisky 
and Green test(13). This test allows to identify the 
patients’ level of adherence and to discriminate whether 
the eventual non-adherence is due to an intentional 
behavior (questions: “do you ever fail to take your 
medication when you feel well?” and “do you ever fail 
to take your medication when you feel unwell with it?”) 
and/or unintentional behavior (questions: “have you 
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ever forgotten to take your medication?” and “are you 
ever careless with the times to take your medication?”). 
The test was validated, translated and used in Brazil(15).
To each answer, the value of (0) zero or (1) one 
was assigned, being the value of (1) one designed for 
negative answers or for positive answers in which the 
frequency stated was once a month or less, and the value 
(0) zero for positive answers with other frequencies. 
The patients who scored four points on the Morisky and 
Green(13) test were classified as “adherent” and those 
who scored from zero to three points as “non-adherent”.
In order to identify the level of patients’ knowledge 
in regards to the medication prescribed to them, the 
Stape scale was used(14). The mentioned instrument 
shows how to translate into percentages the quantity 
(numbers) of information that patients have and directs 
the classification of this knowledge.
This instrument assumes that the level of someone’s 
knowledge about each aspect related to the medications 
(name, dosage and frequency of use) can be scored 
from 0 to 100% and classified into regular ranges which 
represent the following categories: no knowledge (0%), 
very little knowledge (0% ┤ %25%), little knowledge 
(25% ┤ %50%), regular knowledge (50% ┤ %75%) 
and good knowledge (75% - %100%).
Patients’ answers were compared to the information 
contained in the medical records. Each question’s 
answer was classified as right or wrong considering the 
assessed items for each prescribed medication. The 
answer “I do not know” was classified as wrong. In this 
way, if ten medications were prescribed to a person who 
could accurately inform the name of five of them, their 
level of knowledge about the drugs’ names would be of 
50% and included on the “little knowledge” category, 
which corresponds to the points ranges 25% ┤ %50%. 
This procedure was used with each variable related to 
the prescribed medication.
The number of blood tests to measure lithium 
levels in the blood carried out since the beginning of the 
patients’ treatment at the place of study was identified 
through review of medical records. After double entry 
of the data collected in an Excel spreadsheet, the 
descriptive statistics for analysis was used.
Results
Features of the participants in the study
In 2009, 36 people with BD and continuously using 
lithium were assisted at the place of study. All of them 
met the inclusion criteria and agreed to participate in 
the study. The features of the participants can be seen 
on Table 1 below.
Variable N %
Gender
Female 23 63.9
Male 13 36.1
Total 36 100
Age
20 – 30 years old 04 11.1
31 – 40 years old 06 16.7
41 – 50 years old 10 27.8
51 – 60 years old 07 19.4
61 – 70 years old 07 19.4
71 – 80 years old 02 5.6
Total 36 100
Marital status
Married 14 38.9
Single 14 38.9
Divorced 04 11.1
De facto 04 11.1
Total 36 100
Time of diagnosis
0 – 05 years 02 5.6
06 – 10 years 05 13.9
11 – 15 years 08 22.2
16 – 20 years 03 8.3
21 years or more 09 25.0
Do not know 09 25.0
Total 36 100
Occupation
Retired 09 25.0
Unemployed 01 2.8
Employee (registered) 06 16.7
Contractor 08 22.2
Stay-at-home 07 19.4
Others 05 13.9
Total 36 100
Table 1 – Features of participants with affective bipolar 
disorder. Ribeirao Preto, SP, Brazil, 2009
At the time of data collection, three (8.3%) people 
had already shown suicidal tendencies and three 
(8.3%) had a history of suicide attempt. The number 
of hospitalizations varied between zero and 12. It is 
noteworthy that eight (22.2%) people had never been 
hospitalized, 19 (52.8%) patients were hospitalized 
between one and four times, six (16.7%) were 
hospitalized between five and eight times and three 
(8.3%) had been hospitalized more than eight times.
According to the interviews, ten (27.6%) patients 
used to drink alcohol before starting drug therapy and, 
in the period of data collection, this number was reduced 
to two (5.6%) people.
Among the participants, 20 (55.6%) had a monthly 
income of less than four minimum wages. Although 
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35 (97.2%) patients obtained some of the medication 
through the public system, it was possible to identify 
two (5.56%) people who had monthly expenses with 
the purchase of some psychotropic medication and 
five (13.9%) with the purchase of non-psychotropic 
medication. In case of failure of the public system in 
supplying medications, 24 (66.7%) people stated that 
they bought or would buy the medication.
Prescribed drugs
Regarding the types of prescribed medication, 11 
(30.6%) patients were undergoing monotherapy with 
lithium. In relation to the others, 12 (33.3%) used two 
types of medications, eight (22.2%) people used three 
types of medications and five (13.9%) had prescriptions 
for four different medications.
In the participants’ prescriptions, the number of 
tablets to be daily taken varied from one to 13, being 
that 17 (47.2%) took more than four tablets a day. It 
should be mentioned that 21 (58.3%) participants used 
medication three times a day.
It was possible to identify that 21 (58.3%) patients 
reported to have some side effect caused by the 
prescribed drug(s). The most mentioned side effects 
were: weight gain, headache, drowsiness, lethargy, 
shivering, dizziness, gastrointestinal discomfort and dry 
mouth.
Adherence to drug therapy
The adherence to all prescribed medications, 
including lithium, was assessed through the Morisky and 
Green test.
Of those interviewed, only eight (22.2%) had 
adhered to the prescribed drug therapy, 15 (41.7%) had 
not adhered to it as a result of unintentional behavior, 
while 13 (36.1%) were considered non-adherent as a 
result of intentional and unintentional behavior. It can 
be highlighted that, among the 11 patients undergoing 
monotherapy with lithium carbonate, six (54.5%) were 
considered non-adherent.
Participants’ knowledge concerning drug therapy
The patients’ level of knowledge about the name, 
dosage and frequency of prescribed medications is 
presented in Figure 1.
Figure 1 – Distribution of participants according to the level of knowledge 
about the name, frequency and dosage of the prescribed medications
Based on Figure 1, it could be noted that the name 
of the prescribed medications was the most known item 
among the participants, as 29 (80.6%) of them had 
“good knowledge” in relation to it, that is, they were 
within the range of 75% to 100% in the scale that 
assesses the level of knowledge. In the assessment of 
knowledge related to the names of medications, the 
answers that identified the prescribed medication, either 
by its generic name or by any commercial name, were 
accepted as correct. 
Concerning the frequency of these medications, it 
was identified that half of the participants had “good 
knowledge” about this issue.
It was found that 19 (52.8%) patients had little 
knowledge in relation to the daily dosage of the 
medications, since their knowledge had been classified 
into the categories “no knowledge” (0%), “very 
little knowledge” (0%┤25%) or “little knowledge” 
(25%┤50%).
In assessing the abovementioned information in 
relation to the medication dosage, the answers that 
identified the quantity, in units of measure (gram, 
milligram and milliliter), to be taken at each time or 
in a period of 24 hours, in accordance with medical 
prescription, were considered correct.
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Proportion of tests to measure lithium levels in the 
blood performed at the psychological healthcare 
service per year
To identify the proportion of tests to measure 
lithium levels in the blood performed at the psychological 
healthcare service per year, the number of tests 
performed with each patient was divided by the number 
of years of lithium treatment at the psychological 
healthcare service in study.
None of the participants in the present study 
achieved the proportion of two tests performed per year 
at the psychological healthcare service in study. The 
proportion of one test performed per year was achieved 
only in relation to seven (19.4%) patients.
Of all interviewed participants, 14 (38.9%) started 
lithium treatment prior to the period they began to 
attend the psychological healthcare service.
Discussion
As regards the classification of the participants of 
this study, most of them were female. The literature 
points out that men and women are equally likely to 
develop this disorder. The fact that there is a greater 
number of women undergoing treatment for BD control 
may be due to women more often seeking healthcare 
assistance and adhering to treatment better than men(8).
The present study identified the same proportion 
of married and single people diagnosed with BD. The 
literature indicates that there are less married people 
among the population with BD than among the general 
population, which can be a consequence of the disorder’s 
symptoms(16). 
It was noted that only six (16.7%) participants 
stated to have an employment relationship. A study 
suggests that people with BD may have lower productivity 
at work, lower cognitive performance and less favorable 
economic situation than people with depression or 
people without psychological disorders(16). However, 
when compared to people with other disorders, those 
with BD show high academic performance and desire 
to work, although they are faced with the problem of 
unemployment(17).
During the period of data collection, alcohol 
consumption was identified in two (5.6%) patients. The 
literature states that the consumption of alcohol is higher 
in patients with BD than in the general population(18), 
and emphasizes that this behavior is related to poor 
prognosis and low adherence to medication(3,19).
Suicide is one of the most damaging consequences 
of BD(9,20). In this study, three (8.3%) patients who 
had already tried to commit suicide some time in their 
lives were identified, while other three (8.3%) showed 
suicidal tendencies. It is noteworthy that the percentage 
identified in this study is lower than that stated by 
the literature, which points out that between half and 
one quarter of patients with BD had tried to commit 
suicide(9,20). The fact that all participants were taking 
lithium could be a possible explanation for such result, 
since this medication has an important role in reducing 
the risk of patients with BD committing suicide(3,9).
Most participants obtained medications through the 
public healthcare system and 24 (66.7%) interviewed 
participants stated that they would buy the medication 
if the supply by the public system failed. The guarantee 
of access to medication through the public system is of 
utmost importance to the treatment adherence(3) and is 
the subject of concern for patients and their families, 
especially when there are financial constraints that 
preclude the purchase of the prescribed medication(21).
In relation to the therapeutic framework, 25 
(69.4%) participants made use of other medications 
besides the lithium. Most patients took their medications 
three times a day and ingested three or more tables 
daily.
The literature reveals that bipolar patients use 
three medications in average and this aspect increases 
the chances of drug interactions(7). Simultaneous use 
of medications can be a problem in following a medical 
treatment, as it increases the chances of side effects, 
the difficulties of self-administration of prescribed 
medications and, consequently, it increases the 
probability of non-adherence(22).
The majority of the participants in this study 
reported having side effects to the prescribed drugs. 
Indeed, lithium causes side effects such as drowsiness, 
fatigue, lethargy, cognitive problems, weight gain, 
gastrointestinal disorders, shivering, hair loss, polyuria, 
polydipsia, among others(10). These effects may 
compromise the patients’ quality of life, which can be an 
important hurdle to adherence to this drug therapy(3,23).
Most patients with BD did not adhere to drug 
therapy, as identified in previous studies(3,22,24). The 
majority of those who did not adhere to it, had this 
behavior unintentionally, and this is also corroborated 
by the literature(24).
Treatment adherence is closely related to the manner 
in which a person follows medical recommendations(25). 
Low adherence to medications is associated with worse 
prognosis, high recurrence rate(9), hospitalization 
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and suicide(4), besides contributing to treatment 
ineffectiveness and socio-economic damage(7). As for 
lithium, the unintentional non-adherence may favor the 
administration of medications at random times, thus 
increasing the risk of intoxication resulting from dosage 
overlapping.
Patients’ knowledge concerning the therapeutic 
framework is a basic condition for the conduction of the 
treatment if they are responsible for self-administrating 
the drugs(22). In the present study, it was possible to 
note that patients expressed difficulties in adequately 
reporting the dosage of the drugs prescribed and this 
fact can compromise their safety in the use of these 
medications.
Such aspect is compounded by the fact that 
families of people with BD also have little knowledge 
about the medications prescribed to patients, which 
limits their ability to intervene in order to assist patients 
in maintaining therapeutic drug levels(21).
The lack of knowledge about the drug dosage can 
contribute to the ineffectiveness of the treatment, as a 
result of the use of medications below therapeutic levels, 
and can increase toxicity risk, particularly in relation 
to lithium, which is a drug with a narrow therapeutic 
range and severe toxic effects. Therefore, the level of 
knowledge concerning the therapeutic framework and 
the lithium is related to better adherence and lower 
toxicity risk(5).
The serum level of lithium considered therapeutic 
ranges from 0.6 mEq/l to 1.2mEq/l, representing a 
narrow therapeutic range. At levels above this range, 
toxicity signs and symptoms start to appear, such as 
nausea, vomiting, diarrhea, strong shivering, blurred 
vision, muscle contractions, lethargy and confusion(10). 
Patients need to receive information from the healthcare 
team in order to identify these toxic side effects 
because the toxicity caused by lithium brings serious 
complications and can be deadly(5,10,12).
In this context, nurses can effectively intervene 
through psycho-educational strategies. In addition to 
improving the understanding about the treatment, 
psycho-education can promote better management of 
the disorder, adherence to treatment, better insight, 
early recognition of the symptoms, a healthy lifestyle, 
management of stressful situations and repression of 
abuse drugs. This therapeutic approach also helps to 
reduce relapses and hospitalizations and favors a better 
social functioning(26).
In the studied healthcare service, the assessment 
of the proportion of tests performed for each individual 
to measure lithium levels in the blood per year 
revealed that none of the participants had achieved the 
proportion of two tests per year, being that, for most 
of them, not even the proportion of one test per year 
was achieved. The test to measure lithium levels in the 
blood in patients undergoing lithium treatment must be 
performed at least every six months if the patient has a 
stable condition(10). Therefore, none of the participants 
had an appropriate frequency of tests in accordance with 
the minimum recommended by the literature.
An aggravating factor for these findings is the fact 
that 22 (61.1%) participants had lithium prescribed when 
they were already being assisted at the place of study. 
Although in some cases the medication may have been 
prescribed during hospitalization, it is possible that some 
patients had started taking lithium at the place of study.
For those starting the treatment, the number 
of tests recommended is even higher, to allow a safe 
adjustment to the dosage(7,10). Furthermore, depending 
on patients’ health conditions, lithium treatment can 
be started with high dosages, and this requires strict 
monitoring to avoid exceeding the therapeutic limit(7).
Serum monitoring of lithium levels enables to verify 
adherence to treatment, assists with the adjustment 
to dosages and the detection of variations in serum 
concentration of this substance. The provision of these 
tests at healthcare services is an important conduct to 
ensure the safety of patients using lithium.
Final considerations
This study featured 36 patients with affective 
bipolar disorder who are medicated with lithium and 
assisted at a psychological outpatient care center. In 
this research, the sample includes only people with BD 
assisted at only one public service of a country town 
located in the state of Sao Paulo, Brazil, but it is possible 
that the problems identified herein are common to 
patients in other contexts.
In this study, several patients were submitted to 
complex therapeutic methods, had limited knowledge 
about the prescribed medication, especially in relation 
to the dosage, and presented low adherence to the 
drug therapy. None of the participants in this study had 
achieved the minimum proportion of tests per year to 
measure lithium levels in the blood recommended by 
the literature for the treatment and maintenance of 
treatment with lithium.
These limitations indicate the risks in following the 
drug therapy, especially in relation to medications with 
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narrow therapeutic range such as lithium, which can 
considerably compromise people’s prognosis.
As part of the multidisciplinary team, nurses 
should invest in strategies to minimize such limitations 
of healthcare services. Among possible strategies, the 
psycho-educational approach, on an individual or group 
basis with patients and families, should be highlighted. 
Such an approach may contribute to improving patients’ 
knowledge about drug therapy, promoting adherence 
and active participation in the treatment. With greater 
understanding and co-responsibility, patients can 
contribute with the correct administration of medications, 
performance of regular tests, management of side 
effects to lithium and early detection of intoxications.
Therefore, the present study contributes to the 
practice and research in the field of Professional Nursing 
Activity and psychological health, as it points out the 
factors that may compromise the safety of people with BD 
when undergoing drug therapy. It is recommended that 
further studies implementing and assessing managers’ 
and healthcare teams’ strategies aimed at educating, 
supervising, motivating adherence and ensuring tests 
for patients undergoing treatment are developed.
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